Aynure OZTEKİN, Coskun OZTEKİN

Disturbed sleep quality and increased depression scores in alopecia areata patients

Alopecia areata (AA) is a chronic inflammatory disease that affects the hair follicle and sometimes the nails. Comorbidity between alopecia areata and psychiatric disorders is well known. The aim of this study is to evaluate the relationship between the clinical characteristics of AA and sleep quality and depression. This study included 52 patients above 18 years of age who admitted to the dermatology clinic and diagnosed as alopecia areata, and 51 healthy volunteers. Sociodemographic data form, Beck Depression Inventory (BDI), and the Pittsburgh Sleep Quality Index (PSQI) were filled by the patients. Information about the severity of AA, the duration of the disease, the treatments they received, and comorbid illnesses were also recorded. The median BDI total score of the AA patients was higher than that of the control group. In AA patients, PSQI total score and most of the subscale scores were significantly higher than those of the control group. No difference could be found in BDI or PSQI scores according to the presence or absence of poor prognostic criteria. The results of our study support the long-standing relationship between AA and psychiatric disorders and indicate that sleep quality is impaired in addition to the increase in depression level. In particular, a more careful assessment of female AA patients and patients with comorbid atopic dermatitis is important in order not to miss comorbid psychiatric problems.

PDF

___

1. Ito T. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol. 2013; Article ID 348546.

2. Taheri R, Behnam B, Tousi JA, et al. Triggering role of stressful life events in patients with alopecia areata. Acta Dermatovenerol Croat. 2012;20:246-50.

3. Huang KP, Mullangi S, Guo Y, et al. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149:789-94.

4. Alfani S, Antinone V, Mozzetta A, et al. Psychological status of patients with alopecia areata. Acta Derm Venereol. 2012;92:304-6.

5. Chu SY, Chen YJ, Tseng WC, et al. Psychiatric comorbidities in patients with alopecia areata in Taiwan: A case control study. Br J Dermatol. 2012;166:525-31.

6. Hsiao YH, Chen YT, Tseng CM, et al. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea. Sleep. 2015;38:581–6.

7. Seo HM, Kim TL, Kim JS. The risk of alopecia areata and other related autoimmune diseases in patients with sleep disorders: a Korean population-based retrospective cohort study. Sleep. 2018;41:zsy111.

8. Dastagiri J, Shankar M, Supriya T, et al. A current view on alopecia areata. Am J Biol Pharm Res 2016;3:76-82.

9. Chelidze K, Lipner SR. Nail changes in alopecia areata: an update and review. Int J Dermatol. 2018;57:776-83.

10. Kasumagic-Halilovic E, Prohic A. Nail changes in alopecia areata: frequency and clinical presentation. J Eur Acad Dermatol Venereol. 2009;23:240-1.

11. Spano F, Donovan JC. Alopecia areata: Part 1: pathogenesis, diagnosis, and prognosis. Can Fam Physician. 2015;61:751–5.

12. Goh C, Finkel M, Christos PJ, et al. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol. 2006;20:1055-60.

13. Beck AT, Word CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psyc. 1961;4:561-71.

14. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.

15. Olsen EA, Hordinsky MK, Price VH, et al. National Alopecia Areata Foundation: Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation. J Am Acad Dermatol. 2004;51:440-7.

16. Hu J, Chen Z, Gorczynski CP, et al. Sleep-deprived mice show altered cytokine production manifest by perturbations in serum IL-1ra, TNFa, and IL-6 levels. Brain Behav Immun. 2003;17:498-504.

17. Inui S, Hamasaki T, Itami S. Sleep quality in patients with alopecia areata: questionnaire based study. Int J Dermatol. 2014;53:e39-e41.

18. Sellami R, Masmoudi J, Ouali U, et al. The relationship between alopecia areata and alexithymia, anxiety and depression: a case-control study. Indian J Dermatol. 2014;59:421.

19. Baghestani S, Zare S, Seddigh SH. Severity of depression and anxiety in patients with alopecia areata in Bandar Abbas, Iran. Dermatol Reports. 2015;7:6063.

20. Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012;366:1515-25.

21. Aghaei S, Saki N, Daneshmand E, et al. Prevalence of psychological disorders in patients with alopecia areata in comparison with normal subjects. ISRN Dermatol. 2014; Article ID 304370.

22. Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol. 2003;42:434-7.

23. Firooz A, Firoozabadi MR, Ghazisaidi B, et al. Concepts of patients with alopecia areata about their disease. BMC Dermatol. 2005;5:1.

24. Albert PR. Why is depression more prevalent in women? J Psychiatry Neurosci. 2015;40:219-21.

25. Kaaz K, Szepietowski JC, Matusiak L. Influence of itch and pain on sleep quality in atopic dermatitis and psoriasis. Acta Derm Venereol. 2019;99:175-80.